is_manufactured_by has function has role has component vaccinated in route immunizes against disease immunizes recipient immunizes against pathogen has drug brand name mumps measles rubella Rubella virus Measles morbillivirus Mumps orthorubulavirus Homo sapiens M-M-R II vaccine Kallan Roan A Measles-Mumps-Rubella vaccine that is live attenuated and manufactured by Merck & Co, Inc. 601 vaccine MMR II Oliver He M-M-R II BL 101069 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=601 374 375 https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123789.pdf VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=374 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=375 https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm094050.htm M-M-R II is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.For active immunization against invasive meningococcal disease caused by Neisseria meningiditis serogroups A, C, Y, and W-135. Menomune – A/C/Y/W-135 vaccine is approved for use in persons 2 years of age and older. combination vaccine role FDA licensed vaccine role USA licensed human vaccine preventive vaccine function subcutaneous route combination vaccine Canada licensed human vaccine Measles-Mumps-Rubella vaccine Canada licensed vaccine role live attenuated viral vaccine live attenuated vaccine role vaccine monovalent role Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Mumps Virus Vaccine Live, Jeryl Lynn Strain Merck & Co., Inc. M-M-R II